Comparing gene expression profiles of HCmel3 mouse melanomas treated (early-during-treatment, EDT d12-d20 after ACT onset) with gp100-specific adoptive pmel-1 T cell transfer (ACT) versus non-treated control HCmel3 melanomas

This data was also integrated with gene expression profiles from late relapse tumors (GSE40213) to compare changes from early-during-treatment to late relapse versus non-treated. These re-analyzed samples are available in this series.

26